Found "Public health policy": 1,082 results
Sort by
Relevance

Identifying priority antibiotics, their access challenges, and strategies for improving access in Thailand

The Health Intervention and Technology Assessment Program Foundation (HITAP) and the Global Antibiotic Research and Development Partnership (GARDP), through its SECURE initiative, aim to understand the challenges related to antibiotic access in Thailand, develop a list of priority antibiotics, identify mechanisms to address these challenges, and ex

Priority setting of health research topics in thailand

    202-206-2555health research topics,healthy research for healthy nation,Priority setting,ประเทศไทย

การพัฒนากระบวนการประเมินเทคโนโลยีดิจิทัลด้านสุขภาพเพื่อส่งเสริมระบบบริการสุขภาพและสุขภาพประชาชนไทย

โครงการวิจัยเรื่อง “การพัฒนากระบวนการประเมินเทคโนโลยีดิจิทัลด้านสุขภาพเพื่อส่งเสริมระบบบริการสุขภาพและสุขภาพประชาชนไท

Cost-utility analysis of recombinant human erythropoietin in cancer patients with anemia induced by chemotherapy in Thailand (in Thai language)

An increase in the number of cancer patients with anemia has been observed in Thailand due to an increase of cancer patients and the use of chemotherapy for treatment of cancers that cause bone marrow suppression. Although blood transfusion is an effective way of increasing the hemoglobin level in anemic patients, several limitations do exist with

The clinical efficacy and economic evaluation of EC-MPS (Myfortic®) in the treatment of relapse or resistant proliferative lupus nephritis. (in Thai language)

The Clinical Research Collaboration Network in collaboration with the HITAP conducted a clinical test of Randomized Controlled Trial (RCT) regarding the treatment of relapse or resistant proliferative lupus nephritis. The objective of this research was to determine the efficacy of enteric-coated Mycophenolate Sodium combined with corticosteroids fo

Cost-utility analysis of 10- and 13- valent pneumococcal conjugate vaccines in Thailand

A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m

Economic evaluation and feasibility analysis of using three-drug antiretroviral regimens as the standard regimens for the prevention of mother-to-child transmission of HIV in Thailand (in Thai language)

Zidovudine (AZT) plus single dose nevirapine (AZT+sd-NVP) were provided to pregnant women with HIV infection who have CD4 > 200 cell/mm3 for preventing vertical transmission. However, three-drug regimen is provided to pregnant women with HIV infection regardless CD4 cell count in high resource countries. Mother to child transmission rate in preg
10 / Page